Helal Syed, MD, presented “Interim Analysis for Patterns of Erectile Recovery After Robotic‐Assisted Laparoscopic Prostatectomy: A Penile Rehab Study” for the Grand Rounds in Urology audience in April, 2020.
How to cite: Syed, Helal. “Interim Analysis for Patterns of Erectile Recovery After Robotic‐Assisted Laparoscopic Prostatectomy: A Penile Rehab Study” April, 2020. Accessed Apr 2024. https://grandroundsinurology.com/interim-analysis-for-patterns-of-erectile-recovery-after-robotic‐assisted-laparoscopic-prostatectomy-a-penile-rehab-study/
Interim Analysis for Patterns of Erectile Recovery After Robotic‐Assisted Laparoscopic Prostatectomy: A Penile Rehab Study – Summary:
Helal Syed, MD, a urology resident at Brooke Army Medical Center in San Antonio, Texas, discusses investigating the use of pentoxifylline versus PDE-5 inhibitors (PDE-5i) in a small case-control study in patients undergoing robotic-assisted laparoscopic prostatectomy (RALP). He notes the high cost of PDE-5i, which accounted for nearly $82 million of healthcare-related spending in 2015, and how medications such as pentoxifylline could help improve postoperative ED while reducing costs. Finally, Dr. Syed discusses the results of a 17 patient case-control study using pentoxifylline and PDE-5i, which demonstrated no difference in IIEF scores, BMI, or stretched penile length between the treatment groups.
This post is the first in a curated series of lectures originally presented at the Society of Government Service Urologists 2020 Kimbrough Meeting in Charlotte, North Carolina. Other lectures in this series include:
Testosterone Therapy in Men with Organ-Confined Gleason 6-7 Prostate Cancer After Radical Prostatectomy
Microscopic Hematuria Evaluation Stratification: A Machine Learning Approach
